In breast cancer, the up-regulation of IGF1R and the activation of its downstream signaling molecules have been linked to an inhibition of apoptosis, disease progression, increased resistance to cytotoxic chemo-therapeutic drugs or radiotherapy, and to poor prognosis [58]. The gene discussed is IGF1R; the disease is breast carcinoma.